Clin Mol Hepatol.
2025 Jan;31(1):304-307. 10.3350/cmh.2024.0718.
Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- Affiliations
-
- 1Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong
- 2State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong
- KMID: 2563436
- DOI: http://doi.org/10.3350/cmh.2024.0718
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression
- Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma
- The relationship of the activation of ras oncogene to hepatitis Bviruss gene expression in human hepatocellular carcinoma
- Immunohistochemical Study of the Expression of p53, Pan-ras, c-erbB-2 and PCNA in N-Nitrosomorpholine(NNM)-Induced Hepatocellular Carcinoma of Rats
